Skip to main content
Log in

Response to Dr. Panda and Colleagues

  • Response
  • Published:
Neurocritical Care Aims and scope Submit manuscript

The Original Article was published on 12 May 2021

The Original Work to this article was published on 20 May 2020

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Panda PK, Mehra A, Sharawat IK. Role of neurostimulants during acute stroke care: do they improve wakefulness? [letter]. Neurocrit Care. 2021. https://doi.org/10.1007/s12028-021-01257-6.

    Article  PubMed  Google Scholar 

  2. Leclerc AM, Riker RR, Brown CS, May T, Nocella K, Cote J, Eldridge A, Seder DB, Gagnon DJ. Amantadine and modafinil as neurostimulants following acute stroke: a retrospective study of intensive care unit patients. Neurocrit Care. 2021;34(1):102–11.

    Article  CAS  Google Scholar 

  3. Riker RR, Fugate JE. Clinical monitoring scales in acute brain injury: assessment of coma, pain, agitation, and delirium. Neurocrit Care. 2014;21(Suppl 2):S27-37.

    Article  Google Scholar 

  4. Gagnon DJ, Leclerc AM, Riker RR, Brown CS, May T, Nocella K, Cote J, Eldridge A, Seder DB. Amantadine and modafinil as neurostimulants during post-stroke care: a systematic review. Neurocrit Care. 2020;33(1):283–97.

    Article  CAS  Google Scholar 

  5. World Health Organization. Handbook for good clinical research practice (GCP): guidance for implementation. https://www.who.int/medicines/areas/quality_safety/safety_efficacy/gcp1.pdf. Accessed 8 Apr 2021.

Download references

Funding

DJG and RRR are supported in part by a National Institute of General Medical Sciences Grant (1P20GM139745-01).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David J. Gagnon.

Ethics declarations

Conflicts of interest

DJG reports grants from the National Institute of General Medical Sciences, during the conduct of the study (1P20GM139745-01). RRR reports grants from National Institute of General Medical Sciences, during the conduct of the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is related to the original article available at https://doi.org/10.1007/s12028-020-00986-4. This article is a response to the Letter to the Editor available at https://doi.org/10.1007/s12028-021-01257-6

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leclerc, A.M., Riker, R.R., Brown, C.S. et al. Response to Dr. Panda and Colleagues. Neurocrit Care 35, 279–280 (2021). https://doi.org/10.1007/s12028-021-01258-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-021-01258-5

Navigation